Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 10;12(12):1170.
doi: 10.3390/healthcare12121170.

Do Atopic Dermatitis and Psoriasis Have an Impact on Cognitive Decline-Latest Research Review

Marcin Kuryłło  1 , Ewa Mojs  1
Affiliations
Review

Do Atopic Dermatitis and Psoriasis Have an Impact on Cognitive Decline-Latest Research Review

Marcin Kuryłło et al. Healthcare (Basel). .

Abstract

Background: Atopic dermatitis and psoriasis are chronic skin diseases that affect the mental health of patients. The relationship between AD and psoriasis and cognitive processes in patients remains unclear. The aim of the review was to answer the question of whether AD and psoriasis have an impact on cognitive decline in patients.

Method: A systematic literature search was conducted on PubMed and EBSCO to identify case-control, cross-sectional, or cohort studies that evaluated the association between atopic dermatitis and psoriasis and cognitive impairment.

Results: Most of the studies included in the review confirmed cognitive decline in patients with atopic dermatitis and psoriasis.

Conclusions: It seems that atopic dermatitis and psoriasis may negatively affect cognitive processes such as working memory, concentration, attention, and speed of motor reactions. Psychological interventions targeting distorted cognitive processing could improve the quality of life of patients with atopic dermatitis and psoriasis.

Keywords: atopic dermatitis; cognitive impairment; cognitive processes; psoriasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of the review process according to PRISMA guidelines.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Pankowski D., Wytrychiewicz-Pankowska K., Owczarek W. Cognitive impairment in psoriasis patients: A systematic review of case–control studies. J. Neurol. 2022;269:6269–6278. doi: 10.1007/s00415-022-11317-2. - DOI - PMC - PubMed
    1. Chen W.-Y., Chen S.-C., Hsu S.-Y., Lin Y.-A., Shih C.-M., Huang C.-Y., Wang K.-H., Lee A.-W. Annoying Psoriasis and Atopic Dermatitis: A Narrative Review. Int. J. Mol. Sci. 2022;23:4898. doi: 10.3390/ijms23094898. - DOI - PMC - PubMed
    1. Bieber T. Atopic dermatitis. Ann. Dermatol. 2010;22:125–137. doi: 10.5021/ad.2010.22.2.125. - DOI - PMC - PubMed
    1. Chiesa Fuxench Z.C., Block J.K., Boguniewicz M., Boyle J., Ong P.Y. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J. Investig. Dermatol. 2019;139:583–590. doi: 10.1016/j.jid.2018.08.028. - DOI - PubMed
    1. Tsai Y.-C., Tsai T.-F. Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes. Int. J. Mol. Sci. 2022;23:5518. doi: 10.3390/ijms23105518. - DOI - PMC - PubMed

LinkOut - more resources